PNDRI | Researchers: William Hagopian, M.D. Ph.D.

Research Direction

Dr. Hagopian's research focuses on strategies in immunology and molecular biology for predicting and preventing type 1 diabetes before the onset of the disease. These studies include screening over 75,000 newborn babies to determine their risk for developing diabetes and what environmental factors trigger the disease in those with genetic susceptibility. Another study Dr. Hagopian is currently investigating has clinical potential for interrupting the inappropriate autoimmune response that attacks and kills the insulin producing cells in the pancreas. This study shows promise for newly diagnosed patients by preserving the remaining insulin producing cells, which results in easier management of blood sugars.